-
1
-
-
0014887939
-
The concept of immune surveillance
-
Burnet, F.M. The concept of immune surveillance. Prog. Exp. Tumor Res., 1970, 13, 1-27.
-
(1970)
Prog. Exp. Tumor Res
, vol.13
, pp. 1-27
-
-
Burnet, F.M.1
-
2
-
-
77957945021
-
-
House, R.V.; Descotes, J., Eds.; Humana Press: Totowa, NJ
-
Robertson, M.J. In Cytokines in Human Health. House, R.V.; Descotes, J., Eds.; Humana Press: Totowa, NJ, 2007, pp 297-317.
-
(2007)
Cytokines In Human Health
, pp. 297-317
-
-
Robertson, M.J.1
-
3
-
-
11144299492
-
NK cell recognition
-
Lanier, L.L. NK cell recognition. Annu. Rev. Immunol., 2005, 23, 225-274.
-
(2005)
Annu. Rev. Immunol
, vol.23
, pp. 225-274
-
-
Lanier, L.L.1
-
4
-
-
11844254888
-
Macrophage receptors and immune recognition
-
Taylor, P.R.; Martinez-Pomares, L.; Stacey, M.; Lin, H.-H.; Brown, G.D.; Gordon, S. Macrophage receptors and immune recognition. Annu. Rev. Immunol., 2005, 23, 901-944.
-
(2005)
Annu. Rev. Immunol
, vol.23
, pp. 901-944
-
-
Taylor, P.R.1
Martinez-Pomares, L.2
Stacey, M.3
Lin, H.-H.4
Brown, G.D.5
Gordon, S.6
-
5
-
-
0003732734
-
-
Janeway-Jr, C.A.; Travers, P.; Walport, M.; Shlomchik, M.J., Eds., 6th ed. Garland Science: New York
-
Janeway-Jr, C.A.; Travers, P.; Walport, M.; Shlomchik, M.J., Eds. Immunobiology: the immune system in health and disease. 6th ed. Garland Science: New York, 2005.
-
(2005)
Immunobiology: The Immune System In Health and Disease
-
-
-
6
-
-
0004257938
-
-
Paul, W.E., Ed., 5th ed. Williams and Wilkin: Philadelphia
-
Paul, W.E., Ed. Fundamental Immunology. 5th ed. Williams and Wilkin: Philadelphia, 2003.
-
(2003)
Fundamental Immunology
-
-
-
7
-
-
0028201732
-
Tolerance, danger, and the extended family
-
Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol., 1994, 12, 991-1045.
-
(1994)
Annu. Rev. Immunol.
, vol.12
, pp. 991-1045
-
-
Matzinger, P.1
-
8
-
-
9644278053
-
Cytokines in cancer immunity and immunotherapy
-
Smyth, M.J.; Cretney, E.; Kershaw, M.H.; Hayakawa, Y. Cytokines in cancer immunity and immunotherapy. Immunol. Rev., 2004, 202, 275-293.
-
(2004)
Immunol. Rev
, vol.202
, pp. 275-293
-
-
Smyth, M.J.1
Cretney, E.2
Kershaw, M.H.3
Hayakawa, Y.4
-
10
-
-
0035059368
-
Interleukin-18 regulates both Th1 and Th2 responses
-
Nakanishi, K.; Yoshimoto, T.; Tsutsui, H.; Okamura, H. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol., 2001, 19, 423-474.
-
(2001)
Annu. Rev. Immunol
, vol.19
, pp. 423-474
-
-
Nakanishi, K.1
Yoshimoto, T.2
Tsutsui, H.3
Okamura, H.4
-
11
-
-
0036467389
-
IL-1 and IL-18 receptors, and their extended family
-
Sims, J.E. IL-1 and IL-18 receptors, and their extended family. Curr. Opin. Immunol., 2002, 14, 117-122.
-
(2002)
Curr. Opin. Immunol
, vol.14
, pp. 117-122
-
-
Sims, J.E.1
-
12
-
-
62649139025
-
Immunological and inflammatory functions of the interleukin-1 family
-
Dinarello, C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol.,2009, 27, 519-550.
-
(2009)
Annu. Rev. Immunol
, vol.27
, pp. 519-550
-
-
Dinarello, C.A.1
-
13
-
-
0033974776
-
Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18
-
Kim, S.-H.; Eisenstein, M.; Reznikov, L.; Fantuzzi, G.; Novick, D.; Rubinstein, M.; Dinarello, C.A. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc. Natl. Acad. Sci. USA, 2000, 97, 1190-1195.
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, pp. 1190-1195
-
-
Kim, S.-H.1
Eisenstein, M.2
Reznikov, L.3
Fantuzzi, G.4
Novick, D.5
Rubinstein, M.6
Dinarello, C.A.7
-
14
-
-
0037310025
-
Interleukin-18
-
Gracie, J.A.; Robertson, S.E.; McInnes, I.B. Interleukin-18. J. Leukoc. Biol., 2003, 73, 213-224.
-
(2003)
J. Leukoc. Biol
, vol.73
, pp. 213-224
-
-
Gracie, J.A.1
Robertson, S.E.2
McInnes, I.B.3
-
15
-
-
0028845730
-
Cloning of a new cytokine that induces IFN-γ production by T cells
-
Okamura, H.; Tsutsui, H.; Komatsu, T.; Yutsudo, M.; Hakura, A.; Tanimoto, T.; Torigoe, K.; Okura, T.; Nukada, Y.; Hattori, K.; Akita, K.; Namba, M.; Tanabe, F.; Konishi, K.; Fukuda, S.; Kurimoto, M. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature, 1995, 378, 88-91.
-
(1995)
Nature
, vol.78
, pp. 88-91
-
-
Okamura, H.1
Tsutsui, H.2
Komatsu, T.3
Yutsudo, M.4
Hakura, A.5
Tanimoto, T.6
Torigoe, K.7
Okura, T.8
Nukada, Y.9
Hattori, K.10
Akita, K.11
Namba, M.12
Tanabe, F.13
Konishi, K.14
Fukuda, S.15
Kurimoto, M.16
-
16
-
-
0030694235
-
IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB
-
Robinson, D.; Shibuya, K.; Mui, A.; Zonin, F.; Murphy, E.; Sana, T.; Hartley, S.B.; Menon, S.; Kastelein, R.; Bazan, F.; O'Garra, A. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB. Immunity, 1997, 7, 571-581.
-
(1997)
Immunity
, vol.7
, pp. 571-581
-
-
Robinson, D.1
Shibuya, K.2
Mui, A.3
Zonin, F.4
Murphy, E.5
Sana, T.6
Hartley, S.B.7
Menon, S.8
Kastelein, R.9
Bazan, F.10
O'Garra, A.11
-
17
-
-
8544275811
-
Interleukin-18: Recent advances
-
Reddy, P. Interleukin-18: recent advances. Curr. Opin. Hematol., 2004, 11, 405-410.
-
(2004)
Curr. Opin. Hematol
, vol.11
, pp. 405-410
-
-
Reddy, P.1
-
18
-
-
0030766468
-
Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma
-
Micallef, M.J.; Tanimoto, T.; Kohno, K.; Ikeda, M.; Kurimoto, M. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma. Cancer Res., 1997, 57, 4557-4563.
-
(1997)
Cancer Res
, vol.57
, pp. 4557-4563
-
-
Micallef, M.J.1
Tanimoto, T.2
Kohno, K.3
Ikeda, M.4
Kurimoto, M.5
-
19
-
-
8044244220
-
Kurimoto, M. In vivo antitumor effects of murine interferon-γ-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites
-
Micallef, M.J.; Tanimoto, T.; Yoshida, K.K. S.; Hanaya, T.; Kohno, K.; Arai, S.; Tanimoto, T.; Torigoe, K.; Fujii, M.; Ikeda, M.; Kurimoto, M. In vivo antitumor effects of murine interferon-γ-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites. Cancer Immunol. Immunother., 1997, 43, 361-367.
-
(1997)
Cancer Immunol. Immunother.
, vol.3
, pp. 61-367
-
-
Micallef, M.J.1
Tanimoto, T.2
Yoshida, K.K.S.3
Hanaya, T.4
Kohno, K.5
Arai, S.6
Tanimoto, T.7
Torigoe, K.8
Fujii, M.9
Ikeda, M.10
-
20
-
-
2642674449
-
IFN-γ-inducing factor/IL-18 administration mediates IFN-γ-and IL-12-independent antitumor effects
-
Osaki, T.; Peron, J.-M.; Cai, Q.; Okamura, H.; Robbins, P.D.; Kurimoto, M.; Lotze, M.T.; Tahara, H. IFN-γ-inducing factor/IL-18 administration mediates IFN-γ- and IL-12-independent antitumor effects. J. Immunol., 1998, 160, 1742-1749.
-
(1998)
J. Immunol.
, vol.160
, pp. 1742-1749
-
-
Osaki, T.1
Peron, J.-M.2
Cai, Q.3
Okamura, H.4
Robbins, P.D.5
Kurimoto, M.6
Lotze, M.T.7
Tahara, H.8
-
21
-
-
0033565876
-
Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively
-
Hashimoto, W.; Osaki, T.; Okamura, H.; Robbins, P.D.; Kurimoto, M.; Nagata, S.; Peron, J.-M.; Lotze, M.T.; Tahara, H. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively. J. Immunol., 1999, 163, 583-589.
-
(1999)
J. Immunol
, vol.163
, pp. 583-589
-
-
Hashimoto, W.1
Osaki, T.2
Okamura, H.3
Robbins, P.D.4
Kurimoto, M.5
Nagata, S.6
Peron, J.-M.7
Lotze, M.T.8
Tahara, H.9
-
22
-
-
18344386201
-
Interleukin-18 inhibits osteolytic bone metastasis by human lung cancer cells possibly through suppression of osteoclastic bone-resorption in nude mice
-
Iwasaki, T.; Yamashita, K.; Tsujimura, T.; Kashiwamura, S.; Tsutsui, H.; Kaisho, T.; Sugihara, A.; Yamada, N.; Mukai, M.; Yoneda, T.; Okamura, H.; Akedo, H.; Terada, N. Interleukin-18 inhibits osteolytic bone metastasis by human lung cancer cells possibly through suppression of osteoclastic bone-resorption in nude mice. J. Immunother., 2002, 25 (Suppl)1, S52-60.
-
(2002)
J. Immunother
, vol.25
, Issue.1
, pp. 52-60
-
-
Iwasaki, T.1
Yamashita, K.2
Tsujimura, T.3
Kashiwamura, S.4
Tsutsui, H.5
Kaisho, T.6
Sugihara, A.7
Yamada, N.8
Mukai, M.9
Yoneda, T.10
Okamura, H.11
Akedo, H.12
Terada, N.13
-
23
-
-
0036835015
-
Interleukin-18 inhibits lodging and subsequent growth of human multiple myeloma cells in the bone marrow
-
Yamashita, K.; Iwasaki, T.; Tsujimura, T.; Sugihara, A.; Yamada, N.; Ueda, H.; Okamura, H.; Futani, H.; Maruo, S.; Terada, N. Interleukin-18 inhibits lodging and subsequent growth of human multiple myeloma cells in the bone marrow. Oncol. Rep., 2002, 9, 1237-1244.
-
(2002)
Oncol. Rep
, vol.9
, pp. 1237-1244
-
-
Yamashita, K.1
Iwasaki, T.2
Tsujimura, T.3
Sugihara, A.4
Yamada, N.5
Ueda, H.6
Okamura, H.7
Futani, H.8
Maruo, S.9
Terada, N.10
-
24
-
-
12144286607
-
Inhibition by interleukin-18 of the growth of Dunn osteosarcoma cells
-
Okamoto, T.; Yamada, N.; Tsujimura, T.; Sugihara, A.; Nishizawa, Y.; Ueda, H.; Kashiwamura, S.; Tsutsui, H.; Futani, H.; Maruo, S.; Okamura, H.; Terada, N. Inhibition by interleukin-18 of the growth of Dunn osteosarcoma cells. J. Interferon Cytokine Res., 2004, 24, 161-167.
-
(2004)
J. Interferon Cytokine Res
, vol.24
, pp. 161-167
-
-
Okamoto, T.1
Yamada, N.2
Tsujimura, T.3
Sugihara, A.4
Nishizawa, Y.5
Ueda, H.6
Kashiwamura, S.7
Tsutsui, H.8
Futani, H.9
Maruo, S.10
Okamura, H.11
Terada, N.12
-
25
-
-
18344368795
-
Antitumor activity of interleukin-18 against the murine T-cell leukemia/ lymphoma EL-4 in syngeneic mice
-
Akamatsu, S.; Arai, N.; Hanaya, T.; Arai, S.; Tanimoto, T.; Fujii, M.; Kohno, K.; Micallef, M.J.; Ikeda, M.; Kurimoto, M. Antitumor activity of interleukin-18 against the murine T-cell leukemia/ lymphoma EL-4 in syngeneic mice. J. Immunother., 2002, 25 (Suppl 1), S28-34.
-
(2002)
J. Immunother
, vol.25
, Issue.SUPPL. 1
-
-
Akamatsu, S.1
Arai, N.2
Hanaya, T.3
Arai, S.4
Tanimoto, T.5
Fujii, M.6
Kohno, K.7
Micallef, M.J.8
Ikeda, M.9
Kurimoto, M.10
-
26
-
-
0030067276
-
Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma
-
Wigginton, J.M.; Komschlies, K.L.; Back, T.C.; Franco, J.L.; Brunda, M.J.; Wiltrout, R.H. Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma. J. Natl. Cancer Inst., 1996, 88, 38-43.
-
(1996)
J. Natl. Cancer Inst
, vol.88
, pp. 38-43
-
-
Wigginton, J.M.1
Komschlies, K.L.2
Back, T.C.3
Franco, J.L.4
Brunda, M.J.5
Wiltrout, R.H.6
-
27
-
-
0038176025
-
Combined treatment with interleukin-18 and low-dose interleukin-2 induced regression of a murine sarcoma and memory response
-
Son, Y.-I.; Dallal, R.M.; Lotze, M.T. Combined treatment with interleukin-18 and low-dose interleukin-2 induced regression of a murine sarcoma and memory response. J. Immunother., 2003, 26, 234-240.
-
(2003)
J. Immunother
, vol.26
, pp. 234-240
-
-
Son, Y.-I.1
Dallal, R.M.2
Lotze, M.T.3
-
28
-
-
0037370285
-
Synergistic interleukin-18 and low-dose interleukin-2 promote regression of established murine neuroblastoma in vivo
-
Redlinger Jr, R.E.; Mailliard, R.B.; Lotze, M.T.; Barksdale Jr, E.M. Synergistic interleukin-18 and low-dose interleukin-2 promote regression of established murine neuroblastoma in vivo. J. Pediatr. Surg., 2003, 38, 301-307.
-
(2003)
J. Pediatr. Surg
, vol.38
, pp. 301-307
-
-
Redlinger, R.E.1
Mailliard, R.B.2
Lotze, M.T.3
Barksdale, E.M.4
-
29
-
-
0034663047
-
Coadminstration of interleukin-18 and interleukin-12 induces a fatal inflammatory response in mice: Critical role of natural killer cell interferon-γ production and STAT-mediated signal transduction
-
Carson, W.E.; Dierksheide, J.E.; Jabbour, S.; Anghelina, M.; Bouchard, P.; Ku, G.; Yu, H.; Baumann, H.; Shah, M.H.; Cooper, M.A.; Durbin, J.; Caligiuri, M.A. Coadminstration of interleukin-18 and interleukin-12 induces a fatal inflammatory response in mice: critical role of natural killer cell interferon-γ production and STAT-mediated signal transduction. Blood, 2000, 96, 1465-1473.
-
(2000)
Blood
, vol.6
, pp. 1465-1473
-
-
Carson, W.E.1
Dierksheide, J.E.2
Jabbour, S.3
Anghelina, M.4
Bouchard, P.5
Ku, G.6
Yu, H.7
Baumann, H.8
Shah, M.H.9
Cooper, M.A.10
Durbin, J.11
Caligiuri, M.A.12
-
30
-
-
68949092271
-
Coexpression of IL-18 strongly attenuates IL-12-induced systemic toxicity through a rapid induction of IL-10 without affecting its antitumor capacity
-
Rodriguez-Galan, M.C.; Reynolds, D.; Correa, S.G.; Iribarren, P.; Watanabe, M.; Young, H.A. Coexpression of IL-18 strongly attenuates IL-12-induced systemic toxicity through a rapid induction of IL-10 without affecting its antitumor capacity. J. Immunol., 2009, 183, 740-748.
-
(2009)
J. Immunol
, vol.183
, pp. 740-748
-
-
Rodriguez-Galan, M.C.1
Reynolds, D.2
Correa, S.G.3
Iribarren, P.4
Watanabe, M.5
Young, H.A.6
-
31
-
-
0033539579
-
Synergistic inhibition of tumor growth in a murine mammary carcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1γ converting enzyme cDNA
-
Oshikawa, K.; Shi, F.; Rakhmilevich, A.L.; Sondel, P.M.; Mahvi, D.M.; Yang, N.-S. Synergistic inhibition of tumor growth in a murine mammary carcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1γ converting enzyme cDNA. Proc. Natl. Acad. Sci. USA, 1999, 96, 13351-13356.
-
(1999)
Proc. Natl. Acad. Sci. USA
, vol.96
, pp. 13351-13356
-
-
Oshikawa, K.1
Shi, F.2
Rakhmilevich, A.L.3
Sondel, P.M.4
Mahvi, D.M.5
Yang, N.-S.6
-
32
-
-
29044448778
-
Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine
-
Marshall, D.J.; Rudnick, K.A.; McCarthy, S.G.; San Mateo, L.R.; Harris, M.C.; McCauley, C.; Snyder, L.A. Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine. Vaccine, 2006, 24, 244-253.
-
(2006)
Vaccine
, vol.24
, pp. 244-253
-
-
Marshall, D.J.1
Rudnick, K.A.2
McCarthy, S.G.3
San Mateo, L.R.4
Harris, M.C.5
McCauley, C.6
Snyder, L.A.7
-
33
-
-
66149127280
-
Potent antitumor efficacy of interleukin-18 delivered by conditionally replicative adenovirus vector in renal cell carcinoma-bearing nude mice via inhibition of angiogenesis
-
Zheng, J.-N.; Pei, D.-S.; Mao, L.-J.; Liu, X.-Y.; Sun, F.-H.; Zhang, B.-F.; Liu, Y.-Q.; Liu, J.-J.; Li, W.; Han, D. Potent antitumor efficacy of interleukin-18 delivered by conditionally replicative adenovirus vector in renal cell carcinoma-bearing nude mice via inhibition of angiogenesis. Cancer Biol. Ther., 2009, 8, 599-606.
-
(2009)
Cancer Biol. Ther
, vol.8
, pp. 599-606
-
-
Zheng, J.-N.1
Pei, D.-S.2
Mao, L.-J.3
Liu, X.-Y.4
Sun, F.-H.5
Zhang, B.-F.6
Liu, Y.-Q.7
Liu, J.-J.8
Li, W.9
Han, D.10
-
34
-
-
72449179439
-
Oncolytic adenovirus expressing interleukin-18 induces significant antitumor effects against melanoma in mice through inhibition of angiogenesis
-
Zheng, J.-N.; Pei, D.-S.; Mao, L.-J.; Liu, X.-Y.; Sun, F.-H.; Zhang, B.-F.; Liu, Y.-Q.; Liu, J.-J.; Li, W.; Han, D. Oncolytic adenovirus expressing interleukin-18 induces significant antitumor effects against melanoma in mice through inhibition of angiogenesis. Cancer Gene Ther., 2010, 17, 28-36.
-
(2010)
Cancer Gene Ther
, vol.17
, pp. 28-36
-
-
Zheng, J.-N.1
Pei, D.-S.2
Mao, L.-J.3
Liu, X.-Y.4
Sun, F.-H.5
Zhang, B.-F.6
Liu, Y.-Q.7
Liu, J.-J.8
Li, W.9
Han, D.10
-
35
-
-
33846057130
-
Calreticulin exposure dictates the immunogenicity of cancer cell death
-
Obeid, M.; Tesniere, A.; Ghiringhelli, G.M.; Apetoh, L.; Perfettini, J.-L.; Castedo, M.; Mignot, G.; Panaretakis, T.; Casares, N.; Metivier, D.; Larochette, N.; Van Endert, P.; Ciccosanti, F.; Piacentini, M.; Zitvogel, L.; Kroemer, G. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat. Med., 2007, 13, 54-61.
-
(2007)
Nat. Med
, vol.13
, pp. 54-61
-
-
Obeid, M.1
Tesniere, A.2
Ghiringhelli, G.M.3
Apetoh, L.4
Perfettini, J.-L.5
Castedo, M.6
Mignot, G.7
Panaretakis, T.8
Casares, N.9
Metivier, D.10
Larochette, N.11
van Endert, P.12
Ciccosanti, F.13
Piacentini, M.14
Zitvogel, L.15
Kroemer, G.16
-
36
-
-
73249137169
-
Hammond, r.; Danet-Desnoyes, G.; June, C.H.; Powell Jr, D.J.; Coukos, G. Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18
-
Alagkiozidis, I.; Facciabene, A.; Carpenito, C.; Benencia, F.; Jonak, Z.; Adams, S.; Carroll, R.G.; Gimotty, P.A.; Hammond, r.; Danet-Desnoyes, G.; June, C.H.; Powell Jr, D.J.; Coukos, G. Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18. J. Translat. Med., 2009, 7, 104-112.
-
(2009)
J. Translat. Med
, vol.7
, pp. 104-112
-
-
Alagkiozidis, I.1
Facciabene, A.2
Carpenito, C.3
Benencia, F.4
Jonak, Z.5
Adams, S.6
Carroll, R.G.7
Gimotty, P.A.8
-
37
-
-
0034084067
-
IL-18 prevents the development of chronic graft-versus-host disease in mice
-
Okamoto, I.; Kohno, K.; Tanimoto, T.; Iwaki, K.; Ishihara, T.; Akamatsu, S.; Ikegami, H.; Kurimoto, M. IL-18 prevents the development of chronic graft-versus-host disease in mice. J. Immunol., 2000, 164, 6067-6074.
-
(2000)
J. Immunol
, vol.164
, pp. 6067-6074
-
-
Okamoto, I.1
Kohno, K.2
Tanimoto, T.3
Iwaki, K.4
Ishihara, T.5
Akamatsu, S.6
Ikegami, H.7
Kurimoto, M.8
-
38
-
-
0036838671
-
Interleukin 18 preserves perforindependent graft-versus-leukemia effect after allogeneic bone marrow transplantation
-
Reddy, P.; Teshima, T.; Hildebrandt, G.; Duffner, U.; Maeda, Y.; Cooke, K.R.; Ferrara, J.L.M. Interleukin 18 preserves perforindependent graft-versus-leukemia effect after allogeneic bone marrow transplantation. Blood, 2002, 100, 3429-3431.
-
(2002)
Blood
, vol.100
, pp. 3429-3431
-
-
Reddy, P.1
Teshima, T.2
Hildebrandt, G.3
Duffner, U.4
Maeda, Y.5
Cooke, K.R.6
Ferrara, J.L.M.7
-
39
-
-
0035914735
-
Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis
-
Reddy, P.; Teshima, T.; Kukuruga, M.; Ordemann, R.; Liu, C.; Ferrara, J.L.M. Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis. J. Exp. Med., 2001, 194, 1433-1440.
-
(2001)
J. Exp. Med
, vol.194
, pp. 1433-1440
-
-
Reddy, P.1
Teshima, T.2
Kukuruga, M.3
Ordemann, R.4
Liu, C.5
Ferrara, J.L.M.6
-
40
-
-
8644286385
-
Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation
-
Min, C.-K.; Maeda, Y.; Lowler, K.; Liu, C.; Clouthier, S.; Lofthus, D.; Weisiger, E.; Ferrara, J.L.M.; Reddy, P. Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation. Blood, 2004, 104, 3393-3399.
-
(2004)
Blood
, vol.104
, pp. 3393-3399
-
-
Min, C.-K.1
Maeda, Y.2
Lowler, K.3
Liu, C.4
Clouthier, S.5
Lofthus, D.6
Weisiger, E.7
Ferrara, J.L.M.8
Reddy, P.9
-
41
-
-
0038784377
-
Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects
-
Reddy, P.; Teshima, T.; Hildebrandt, G.; Williams, D.L.; Cooke, K.R.; Ferrara, J.L.M. Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects. Blood, 2003, 101, 2877-2885.
-
(2003)
Blood
, vol.101
, pp. 2877-2885
-
-
Reddy, P.1
Teshima, T.2
Hildebrandt, G.3
Williams, D.L.4
Cooke, K.R.5
Ferrara, J.L.M.6
-
42
-
-
77951623928
-
Hematopoietic stem cell transplantation: A global perspective
-
Gratwohl, A.; Baldomero, H.; Aljurf, M.; Pasquini, M.C.; Bouzas, L.F.; Yoshimi, A.; Szer, J.; Lipton, J.; Schwendener, A.; Gratwohl, M.; Frauendorfer, K.; Niederwieser, D.; Horowitz, M.; Kodera, Y. Hematopoietic stem cell transplantation: a global perspective. JAMA, 2010, 202, 1617-1624.
-
(2010)
JAMA
, vol.202
, pp. 1617-1624
-
-
Gratwohl, A.1
Baldomero, H.2
Aljurf, M.3
Pasquini, M.C.4
Bouzas, L.F.5
Yoshimi, A.6
Szer, J.7
Lipton, J.8
Schwendener, A.9
Gratwohl, M.10
Frauendorfer, K.11
Niederwieser, D.12
Horowitz, M.13
Kodera, Y.14
-
44
-
-
0036847429
-
Interleukin-12 immunotherapy after autologous stem cell transplantation for hematologic malignancies
-
Robertson, M.J.; Pelloso, D.; Abonour, R.; Hromas, R.A.; Nelson Jr, R.P.; Wood, L.; Cornetta, K. Interleukin-12 immunotherapy after autologous stem cell transplantation for hematologic malignancies. Clin. Cancer Res., 2002, 8, 3383-3393.
-
(2002)
Clin. Cancer Res
, vol.8
, pp. 3383-3393
-
-
Robertson, M.J.1
Pelloso, D.2
Abonour, R.3
Hromas, R.A.4
Nelson, R.P.5
Wood, L.6
Cornetta, K.7
-
45
-
-
1642303259
-
Immunological consequences of interleukin 12 administration after autologous stem cell transplantation
-
Pelloso, D.; Cyran, K.; Timmons, L.; Williams, B.T.; Robertson, M.J. Immunological consequences of interleukin 12 administration after autologous stem cell transplantation. Clin. Cancer Res., 2004, 10, 1935-1942.
-
(2004)
Clin. Cancer Res
, vol.10
, pp. 1935-1942
-
-
Pelloso, D.1
Cyran, K.2
Timmons, L.3
Williams, B.T.4
Robertson, M.J.5
-
46
-
-
23044498580
-
Impaired interferon-γ production as a consequence of STAT4 deficiency after autologous hematopoietic stem cell transplantation for lymphoma
-
Robertson, M.J.; Chang, H.-C.; Pelloso, D.; Kaplan, M.H. Impaired interferon-γ production as a consequence of STAT4 deficiency after autologous hematopoietic stem cell transplantation for lymphoma. Blood, 2005, 106, 963-970.
-
(2005)
Blood
, vol.106
, pp. 963-970
-
-
Robertson, M.J.1
Chang, H.-C.2
Pelloso, D.3
Kaplan, M.H.4
-
47
-
-
67651097885
-
Impaired development of human Th1 cells in patients with deficient expression of STAT4
-
Chang, H.-C.; Han, L.; Goswami, R.; Nguyen, E.T.; Pelloso, D.; Robertson, M.J.; Kaplan, M.H. Impaired development of human Th1 cells in patients with deficient expression of STAT4. Blood, 2009, 113, 5887-5890.
-
(2009)
Blood
, vol.113
, pp. 5887-5890
-
-
Chang, H.-C.1
Han, L.2
Goswami, R.3
Nguyen, E.T.4
Pelloso, D.5
Robertson, M.J.6
Kaplan, M.H.7
-
48
-
-
0034254177
-
The p38 mitogen-activated protein kinase is required for IL-12-induced IFN-γ expression
-
Zhang, S.; Kaplan, M.H. The p38 mitogen-activated protein kinase is required for IL-12-induced IFN-γ expression. J. Immunol., 2000, 165, 1375-1380.
-
(2000)
J. Immunol.
, vol.165
, pp. 1375-1380
-
-
Zhang, S.1
Kaplan, M.H.2
-
49
-
-
33847352726
-
Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancer
-
Robertson, M.J.; Mier, J.W.; Logan, T.; Atkins, M.; Koon, H.; Koch, K.M.; Kathman, S.; Pandite, L.N.; Oei, C.; Kirby, L.C.; Jewell, R.C.; Bell, W.N.; Thurmond, L.M.; Weisenbach, J.; Roberts, S.; Dar, M.M. Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancer. Clin. Cancer Res., 2006, 12, 4265-4273.
-
(2006)
Clin. Cancer Res
, vol.12
, pp. 4265-4273
-
-
Robertson, M.J.1
Mier, J.W.2
Logan, T.3
Atkins, M.4
Koon, H.5
Koch, K.M.6
Kathman, S.7
Pandite, L.N.8
Oei, C.9
Kirby, L.C.10
Jewell, R.C.11
Bell, W.N.12
Thurmond, L.M.13
Weisenbach, J.14
Roberts, S.15
Dar, M.M.16
-
50
-
-
50349092728
-
A dose-escalation study of recombinant human interleukin-18 using two different schedules of administration in patients with cancer
-
Robertson, M.J.; Kirkwood, J.M.; Logan, T.F.; Koch, K. M.; Kathman, S.; Kirby, L.C.; Bell, W.N.; Thurmond, L.M.; Weisenbach, J.; Dar, M.M. A dose-escalation study of recombinant human interleukin-18 using two different schedules of administration in patients with cancer. Clin. Cancer Res., 2008, 14, 3462-3469.
-
(2008)
Clin. Cancer Res
, vol.14
, pp. 3462-3469
-
-
Robertson, M.J.1
Kirkwood, J.M.2
Logan, T.F.3
Koch, K.M.4
Kathman, S.5
Kirby, L.C.6
Bell, W.N.7
Thurmond, L.M.8
Weisenbach, J.9
Dar, M.M.10
-
51
-
-
33645329373
-
PK and PD of recombinant human IL-18 (rhIL-18) administered IV in repeated cycles to patients with solid tumors
-
abstract 2535
-
Koch, K.M.; Roman, J.R.; Jaworski, D.; Godillot, P.; Robertson, M.J.; Kirkwood, J.M.; Lucas, S.; Bell, B.; Dar, M.M. PK and PD of recombinant human IL-18 (rhIL-18) administered IV in repeated cycles to patients with solid tumors. J. Clin. Oncol., 2005, 23, 174s (abstract 2535).
-
(2005)
J. Clin. Oncol
, vol.23
-
-
Koch, K.M.1
Roman, J.R.2
Jaworski, D.3
Godillot, P.4
Robertson, M.J.5
Kirkwood, J.M.6
Lucas, S.7
Bell, B.8
Dar, M.M.9
-
52
-
-
68549131676
-
Phase I dose escalation study to assess tolerability and pharmcokinetics of recombinant human interleukin-18 (rhIL-18) administered as fourteen daily subcutaneous injections in patients with solid tumors
-
abstract 2591
-
Lewis, N.; Gollob, J.; Cohen, R.; Thoreson, M.; Oei, C.; Kirby, L.; Koch, K.; Thurmond, L.; Dar, M.; Bell, W. Phase I dose escalation study to assess tolerability and pharmcokinetics of recombinant human interleukin-18 (rhIL-18) administered as fourteen daily subcutaneous injections in patients with solid tumors. J. Clin. Oncol., 2004, 22, 185s (abstract 2591).
-
(2004)
J. Clin. Oncol
, vol.22
-
-
Lewis, N.1
Gollob, J.2
Cohen, R.3
Thoreson, M.4
Oei, C.5
Kirby, L.6
Koch, K.7
Thurmond, L.8
Dar, M.9
Bell, W.10
-
53
-
-
60849134283
-
A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma
-
Tarhini, A.A.; Millward, M.; Mainwaring, P.; Kefford, R.; Logan, T.; Pavlick, A.; Kathman, S.J.; Laubscher, K.H.; Dar, M.M.; Kirkwood, J.M. A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma. Cancer, 2009, 115, 859-868.
-
(2009)
Cancer
, vol.115
, pp. 859-868
-
-
Tarhini, A.A.1
Millward, M.2
Mainwaring, P.3
Kefford, R.4
Logan, T.5
Pavlick, A.6
Kathman, S.J.7
Laubscher, K.H.8
Dar, M.M.9
Kirkwood, J.M.10
-
54
-
-
85036758302
-
A phase I trial evaluating the safety and biological activity of iboctadekin (rhIL-18) in combination with rituximab in patients with CD20+ Bcell non-Hodgkin's lymphoma
-
abstract 8566
-
Robertson, M.J.; Kline, J.; Bauman, J.; Gardner, O.; Jonak, Z.; Koch, K. M.; Murray, S.C.; Weisenbach, J.; Toso, J. A phase I trial evaluating the safety and biological activity of iboctadekin (rhIL-18) in combination with rituximab in patients with CD20+ Bcell non-Hodgkin's lymphoma. J. Clin. Oncol., 2009, 27, 450s (abstract 8566).
-
(2009)
J. Clin. Oncol
, vol.27
-
-
Robertson, M.J.1
Kline, J.2
Bauman, J.3
Gardner, O.4
Jonak, Z.5
Koch, K.M.6
Murray, S.C.7
Weisenbach, J.8
Toso, J.9
|